Jefferies Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Jefferies Financial Group’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.33M	Hold	118,810	–	–	0.06%	233
2025 Q4	$9.73M	Buy	118,810 +5,741	+5%	+$429K	0.05%	326
2025 Q3	$6.72M	Sell	113,069 -49,927	-31%	-$2.46M	0.03%	298
2025 Q2	$6.6M	Buy	162,996 +84,188	+107%	+$3.79M	0.06%	234
2025 Q1	$4.05M	Sell	78,808 -341,950	-81%	-$16.9M	0.04%	355
2024 Q4	$23.3M	Hold	420,758	–	–	0.14%	109
2024 Q3	$13.8M	Hold	420,758	–	–	0.1%	127
2024 Q2	$11.4M	Buy	420,758 +150,000	+55%	+$5.04M	0.12%	134
2024 Q1	$9.84M	Sell	270,758 -110,000	-29%	-$3.23M	0.09%	173
2023 Q4	$7.71M	Buy	380,758 +50,000	+15%	+$835K	0.05%	282
2023 Q3	$5.88M	Sell	330,758 -25,000	-7%	-$442K	0.05%	298
2023 Q2	$6.43M	Sell	355,758 -90,000	-20%	-$1.43M	0.06%	295
2023 Q1	$5.6M	Hold	445,758	–	–	0.05%	331
2022 Q4	$6.53M	Buy	+445,758	New	+$7.38M	0.05%	323

Other funds holding TARS

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Financial Group's TARS Position: Q1 2026 in Review

Jefferies Financial Group held its Tarsus Pharmaceuticals (TARS) position steady in Q1 2026 at 118,810 shares worth $8.33M. The position accounts for 0.06% of the portfolio, ranked #233.

Jefferies Financial Group first reported a position in TARS in Q4 2022 and has held it in 14 quarters since. The position peaked at $23.3M in Q4 2024. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

Jefferies Financial Group held 118,810 shares of Tarsus Pharmaceuticals worth $8.33M as of Q1 2026.
Jefferies Financial Group left its Tarsus Pharmaceuticals share count unchanged in Q1 2026.
Tarsus Pharmaceuticals made up 0.06% of Jefferies Financial Group's portfolio in Q1 2026, its #233 holding.
Jefferies Financial Group first reported a position in Tarsus Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Jefferies Financial Group's Tarsus Pharmaceuticals position peaked at $23.3M in Q4 2024.
253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.